- Report Quarter 1
- Report Quarter 1
- Report Quarter 1
- Report Quarter 1
- Report Quarter 1
- Report Quarter 1
- Report Quarter 1
- Report Quarter 1
- Report Quarter 1
- Report Quarter 1
| ART | |
| Pre-ART | |
| Isonazid Prevention Therapy (IPT) | |
| Home Based Care | |
| STI | |
| VCCT | |
| Linked Response |
| ART | |
| Pre-ART | |
| Isonazid Prevention Therapy (IPT) | |
| Home Based Care | |
| STI | |
| VCCT | |
| Linked Response |
| ART | |
| Pre-ART | |
| Isonazid Prevention Therapy (IPT) | |
| Home Based Care | |
| STI | |
| VCCT | |
| Expose Infant |
| ART | |
| Pre-ART | |
| Isonazid Prevention Therapy (IPT) | |
| Home Based Care | |
| STI | |
| VCCT | |
| Expose Infant |
| របាយការណ៍ការព្យាបាលដោយឱសថប្រឆាំងមេរោគអេដស៍ | |
| របាយការណ៍ធ្វើតេស្តឈាមរកមេរោគអេដស៍ | |
| របាយការណ៍កុមារប្រឈម និងការឆ្លងមេរោគអេដស៍ | |
| របាយការណ៍ជំងឺកាមរោគ |
| Summary HIV/AIDS and HCV-HIV Co-infection | |
| Report Detail HIV/AIDS and HCV-HIV Co-infection (Path 1) | |
| Report Detail HIV/AIDS and HCV-HIV Co-infection (Path 2) | |
| Report Positive Prevention, TB-HIV and Pregnance Women | |
| Report HCV-HIV Co-Infection | |
| Expose Infant | |
| Report VCCT | |
| Report STI | |
| Report B-IACM |
| Summary HIV/AIDS and HCV-HIV Co-infection | |
| Report Detail HIV/AIDS and HCV-HIV Co-infection (Path 1) | |
| Report Detail HIV/AIDS and HCV-HIV Co-infection (Path 2) | |
| Report Positive Prevention, TB-HIV and Pregnance Women | |
| Report HCV-HIV Co-Infection | |
| Report on Partner Notification Tracing and Testing (PNTT) | |
| Report VCCT | |
| Report STI | |
| Report Boosted CoPCT KP | |
| Report B-IACM |
| ART | |
| Pre-ART | |
| Isonazid Prevention Therapy (IPT) | |
| VCCT | |
| Expose Infant |
| ART | |
| Pre-ART | |
| Isonazid Prevention Therapy (IPT) | |
| STI | |
| VCCT | |
| Expose Infant |
| ART | |
| Pre-ART | |
| Isonazid Prevention Therapy (IPT) | |
| VCCT | |
| STI | |
| Expose Infant |
